🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Treatment Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are urged to message these accounts privately for supplier links, while also obtaining promotional offers.

Thriving Trade on Social Networks

Separately, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and assertions of rapid UK delivery. Vendors promote the substance there before directing customers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Professionals Voice Concerns

However, doctors and chemists have warned that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could result in users administering products of unknown origin.

Some professionals said the demand for retatrutide could be connected to the rising cost of licensed weight loss products such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to penalties, prosecution or imprisonment.

Platform Reaction and Material Removal

According to the social media company, the platform has taken down problematic material and prohibited related hashtags and query recommendations. The company stated it was committed to keeping the service secure and allocating resources in enhancing compliance measures.

Digital Trading Operations

Investigations also discovered groups with up to nine thousand participants marketing retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with numerous of members, populated with images of weight loss, positive testimonials and detailed guides for preparing or administering at home.

After moments of entering one community, a seller shared WhatsApp details, where the majority of purchases take place. The vendor provided an instruction manual and promised shipping within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about body mass, medical conditions or previous experience.

Item Information and Pricing

Inside these communities, messages display dark colored parcels with postal service labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Actions

A representative for Telegram said it regularly moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting substances they can’t verify. Even if the research behind this drug is valid, these online versions may not include what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.

Her staff has previously seen patients harmed by self-injection from unverified suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to potentially significant medical dangers”.